CONMED Corporation

Healthcare · Medical Devices

46.20$ +3.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

CONMED Corporation (CNMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 343 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CNMD
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	305	327	312	332	317	346	319	343	339	373	317	343	1,373
Cost of Revenue	137	145	140	148	138	148	152	163	181	160	134	146	620
Gross Profit	168	182	172	184	179	198	168	181	158	213	183	197	752
Research & Development	12	14	14	14	14	13	13	14	14	15	16	16	61
Selling, General & Administrative	125	118	123	123	100	133	149	121	122	167	142	146	576
Total Operating Expenses	138	132	137	137	113	146	156	139	139	146	158	161	604
Operating Income	30	50	35	47	66	52	11	42	19	67	25	36	148
Interest Expense	10	9.5	9.6	9.6	9.3	8.9	8.3	7.8	7.6	7.4	7.1	7.9	30
Pre-Tax Income	20	41	25	38	56	44	7.7	30	4.3	29	18	31	83
Income Tax Expense	4.4	7.6	5.7	7.5	7.5	9.9	1.6	8.5	1.4	13	4.5	8.3	27
Net Income	16	33	20	30	49	34	6.0	21	2.9	17	14	23	56
EBITDA	43	68	53	65	84	71	29	51	25	55	38	61	180

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings